Cargando…

Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report

INTRODUCTION: Angiotensin converting enzyme inhibitors (ACEI) are a common class of medications prescribed to patients for hypertension. Anti-hypertensive use is not normally considered an important factor when treating patients with crotalid envenomations; however, in combination with the venom in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampson, Christopher Scott, Schwarz, Evan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438947/
https://www.ncbi.nlm.nih.gov/pubmed/37595314
http://dx.doi.org/10.5811/cpcem.1463
_version_ 1785092830802214912
author Sampson, Christopher Scott
Schwarz, Evan
author_facet Sampson, Christopher Scott
Schwarz, Evan
author_sort Sampson, Christopher Scott
collection PubMed
description INTRODUCTION: Angiotensin converting enzyme inhibitors (ACEI) are a common class of medications prescribed to patients for hypertension. Anti-hypertensive use is not normally considered an important factor when treating patients with crotalid envenomations; however, in combination with the venom in this patient, it may have resulted in angioedema. CASE REPORT: A 65-year-old male on ACEI presented to his community emergency department following a snake envenomation to his thumb. Six vials of Crotalidae polyvalent immune fab were administered, and he was transferred to a referral center. Approximately 18 hours after the envenomation, the patient complained of tongue swelling and difficulty speaking. There was evidence of angioedema, with the right side of the tongue significantly enlarged compared to the left. He was intubated for airway protection and remained on a ventilator for three days. CONCLUSION: Angiotensin converting enzyme inhibitors may potentiate the effects of exogenous bradykinin as some snake venom has naturally occurring bradykinin, which may further amplify its effects. Extra vigilance may be warranted for the development of angioedema in patients receiving ACEI.
format Online
Article
Text
id pubmed-10438947
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine
record_format MEDLINE/PubMed
spelling pubmed-104389472023-08-19 Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report Sampson, Christopher Scott Schwarz, Evan Clin Pract Cases Emerg Med Case Report INTRODUCTION: Angiotensin converting enzyme inhibitors (ACEI) are a common class of medications prescribed to patients for hypertension. Anti-hypertensive use is not normally considered an important factor when treating patients with crotalid envenomations; however, in combination with the venom in this patient, it may have resulted in angioedema. CASE REPORT: A 65-year-old male on ACEI presented to his community emergency department following a snake envenomation to his thumb. Six vials of Crotalidae polyvalent immune fab were administered, and he was transferred to a referral center. Approximately 18 hours after the envenomation, the patient complained of tongue swelling and difficulty speaking. There was evidence of angioedema, with the right side of the tongue significantly enlarged compared to the left. He was intubated for airway protection and remained on a ventilator for three days. CONCLUSION: Angiotensin converting enzyme inhibitors may potentiate the effects of exogenous bradykinin as some snake venom has naturally occurring bradykinin, which may further amplify its effects. Extra vigilance may be warranted for the development of angioedema in patients receiving ACEI. University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2023-06-26 /pmc/articles/PMC10438947/ /pubmed/37595314 http://dx.doi.org/10.5811/cpcem.1463 Text en © 2023 Sampson et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) License. See: http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Case Report
Sampson, Christopher Scott
Schwarz, Evan
Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report
title Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report
title_full Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report
title_fullStr Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report
title_full_unstemmed Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report
title_short Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report
title_sort delayed-onset angioedema following a snakebite in a patient on ace inhibitors: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438947/
https://www.ncbi.nlm.nih.gov/pubmed/37595314
http://dx.doi.org/10.5811/cpcem.1463
work_keys_str_mv AT sampsonchristopherscott delayedonsetangioedemafollowingasnakebiteinapatientonaceinhibitorsacasereport
AT schwarzevan delayedonsetangioedemafollowingasnakebiteinapatientonaceinhibitorsacasereport